Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes
Open Access
- 30 June 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 50 (6), 1209-1215
- https://doi.org/10.1194/jlr.p800040-jlr200
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Mechanism of Action of NiacinThe American Journal of Cardiology, 2008
- Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic SyndromeJournal of Clinical Endocrinology & Metabolism, 2008
- Adiponectin Is an Important Determinant of ApoA-I CatabolismArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- TRL, IDL, and LDL Apolipoprotein B-100 and HDL Apolipoprotein A-I Kinetics as a Function of Age and Menopausal StatusArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable IsotopesArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)The American Journal of Cardiology, 2003
- In Vivo Evidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2001
- Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A MetabolismJCI Insight, 1979
- Diabetes and cardiovascular risk factors: the Framingham study.Circulation, 1979